MediciNova Announces New Data regarding MN-166 (ibudilast) in Uveal Melanoma Presented at the CURE OM Global Science Meeting

November 10, 2021
11:00 pm

MediciNova Announces New Data regarding MN-166 (ibudilast) in Uveal Melanoma Presented at the CURE OM Global Science Meeting

LA JOLLA, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Grazia Ambrosini,…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

A Healthcare Pioneer With 24.51% Upside Potential

February 18, 2026

O’Leary’s bold crypto purge reveals why institutions are capping crypto exposure at a dangerous 3%

February 18, 2026

Evaluating A 6.50% Dividend Yield Amid Growth Prospects

February 18, 2026

How Speculation and Utility Intersect in the Crypto Market

February 18, 2026

Assessing Applied Materials (AMAT) After A 108% One Year Share Price Surge

February 18, 2026

Crypto Sentiment Reaches Historically Low Levels

February 18, 2026

Is Louisiana Pacific (LPX) Pricing Still Justified After Recent Share Price Pullback

February 18, 2026

Ripple Could Be the Real Winner of the White House’s New Crypto Clarity Push

February 18, 2026